$34.72
+0.290 (+0.84%)
At Close: Aug 05, 2026
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q1 2021 Results - Earnings Call Transcript
02:32pm, Wednesday, 28'th Apr 2021
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q1 2021 Results - Earnings Call Transcript
Major COVID-19 Vaccine Makers Reject Teva Pharmaceutical's Offer For Jab Manufacture Help: FT
02:29pm, Wednesday, 28'th Apr 2021
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) CEO said that its offers to help manufacture coronavirus vaccines were turned down by major vaccine makers, despite having production capacity ready
What's Behind Teva's Mixed Q1 Results
10:55am, Wednesday, 28'th Apr 2021
Increased competition for several of its top products continued to affect the drugmaker's performance in Q1.
Exclusive: Teva Pharm unlikely to reach deals to co-produce vaccines -CEO
10:10am, Wednesday, 28'th Apr 2021
Israel's Teva Pharmaceutical Industries is not likely to reach deals with COVID vaccine makers to co-produce the vaccines although discussions are still ongoing, chief executive Kare Schultz told Reut
Teva's stock gains after it beats earnings expectations
07:40am, Wednesday, 28'th Apr 2021
Shares of Teva Pharmaceutical Industries Ltd. gained 0.6% in premarket trading after the drug maker beat earnings expectations for the first quarter, even though sales of its multiple-sclerosis drug c
J&J, other drugmakers go to trial in California in $50 billion case over 'deadly legacy' of opioids
06:39pm, Monday, 19'th Apr 2021
Four drugmakers helped cause the deadly U.S. opioid epidemic by deceptively marketing their drugs and downplaying their addictive risks, a lawyer for several California counties argued on Monday at th
3 Generic Drug Stocks to Watch Amid COVID-Related Recovery
09:09am, Wednesday, 14'th Apr 2021
3 Generic Drug Stocks to Watch Amid COVID-Related Recovery
Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate)
03:00am, Thursday, 08'th Apr 2021
AMSTERDAM--(BUSINESS WIRE)--Teva Pharmaceuticals Europe announced that it has received EU Marketing Authorisation for Seffalair Spiromax and its duplicate BroPair Spiromax (salmeterol xinafoate/ fluti
Abercrombie, Pfizer, Teva and More of Wednesday Afternoon Analyst Calls
11:45am, Wednesday, 07'th Apr 2021
With the trading day approaching halfway over, the broad markets were trading marginally positive.
4 Value Stocks That Can Double in a Biden Bull Market
05:51am, Sunday, 21'st Mar 2021
Value stocks have historically outperformed during economic recoveries -- and these companies look poised to shine under the new administration.
Connect Biopharma Pursues $150 Million U.S. IPO Plan
03:43pm, Tuesday, 16'th Mar 2021
Connect Biopharma Pursues $150 Million U.S. IPO Plan
TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced its launch of the first avai
A Giant Pension Bought Up PG&E, Zoom, and a Stock Elon Musk Loves
07:00am, Sunday, 28'th Feb 2021
South Korea's National Pension Service started investments in PG&E and Etsy, bought more Zoom stock, and sold most of its Teva position in the fourth quarter.
Is Teva Pharmaceuticals a Safe Stock to Buy Now?
06:20am, Sunday, 21'st Feb 2021
The largest generic drug manufacturer in the world can be bought for pennies on the dollar.
2 Stocks I'd Avoid at All Costs
06:30am, Saturday, 20'th Feb 2021
If you're looking for stability or growth, look elsewhere.
Sign In
Buy TEVA